Straits Research Pvt Ltd
Pharmacogenomics Market Size is projected to reach USD 11.79 Billion by 2030, growing at a CAGR of 8.47%: Straits Research
23 août 2022 15h35 HE | Straits Research
New York, USA, Aug. 23, 2022 (GLOBE NEWSWIRE) -- The global pharmacogenomics market is expected to grow due to the constantly rising need for treating fatal diseases like cancer and increasing...
myriad_S_stacked.png
Myriad Genetics Partners with Institut für Hämopathologie Hamburg and Centre Georges-Francois LeClerc to Expand Access to Genetic Testing in Europe
16 août 2022 01h05 HE | Myriad Genetics, Inc.
Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, FranceLatest expansions represent Myriad’s commitment to growing international lab partner program SALT LAKE CITY, Aug....
TIP_link_300x300.jpg
Genotyping Market Size Worth $79.4Bn by 2028 at 20.1% CAGR, Colossal Market Share (by F. Hoffmann-La Roche Ltd. & Illumina, Inc.), Lead by Product and Services Segment, Deep Dive Global Analysis by The Insight Partners
30 juin 2022 09h48 HE | The Insight Partners
New York, June 30, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Genotyping Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service...
Sema4_Logo2021_Primary_Gradient.png
Sema4 to Participate at Two Investor Conferences in June 2022
26 mai 2022 08h00 HE | Sema4
STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate...
Meticulous Logo.png
Veterinary Molecular Diagnostics Market Worth $1.61 Billion by 2029 - Exclusive Report by Meticulous Research®
23 mai 2022 08h00 HE | Meticulous Market Research Pvt. Ltd.
Redding, California, May 23, 2022 (GLOBE NEWSWIRE) -- According to a new market research report, “Veterinary Molecular Diagnostics Market by Product (Kits & Reagents, System & Software),...
Public Health Genetics Week
The Third Annual Public Health Genetics Week is Around the Corner - May 23-27, 2022 BETHESDA, Md., May 10, 2022 (GLOBE NEWSWIRE) -- The National Coordinating Center for the Regional Genetics Network (NCC) is excited to announce that the third annual Public Health Genetics Week will...
Sema4_Logo2021_Primary_Gradient.png
Sema4 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 mai 2022 16h05 HE | Sema4
STAMFORD, Conn., May 04, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that, effective as of May 2, 2022, the...
Sema4_Logo2021_Primary_Gradient.png
Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms
02 mai 2022 07h45 HE | Sema4
Acquisition creates an AI-driven advanced health intelligence company, now leveraging one of the largest genomic testing platforms in the U.S. Katherine Stueland, former President and CEO of GeneDx,...
Sema4_Logo2021_Primary_Gradient.png
Sema4 to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
26 avr. 2022 16h05 HE | Sema4
STAMFORD, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced it will release financial results for...
Sema4_Logo2021_Primary_Gradient.png
Sema4 Achieves HITRUST CSF Certification
06 avr. 2022 08h00 HE | Sema4
STAMFORD, Conn., April 06, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that its health intelligence platform,...